✦ LIBER ✦

PCV31 LONG-TERM COST-EFFECTIVENESS OF RIMONABANT IN GERMANY

✍ Scribed by O Pirk; F Hessel; W Kotowa; N Hertel

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PCV26 COST-EFFECTIVENESS OF CLOPIDOGREL

✍ C Jerjes-Sanchez; A Trujillo; MA Ramos; I Hernandez; R Alvarado; A Cruz; FJ Rang 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 67 KB

PCV5 LONG-TERM COST-EFFECTIVENESS OF CLO

✍ B Brüggenjürgen; B Ehlken 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 66 KB

PCV45 LONG-TERM COST-EFFECTIVENESS OF PR

✍ K Sridhar; JL Mahon 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 66 KB

PCV31 COST-EFFECTIVENESS OF CONTRAST ECH

✍ R Richardson; S Cottrell; M Aristides; M Chambers 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 64 KB

PCV26 COST-EFFECTIVENESS OF CANDESARTAN

✍ M Voelkl; O Pirk; V Juenger 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 64 KB

Long-term cost-effectiveness of clopidog

✍ Zefeng Zhang; Paul Kolm; Frederique Mosse; Joseph Jackson; Liping Zhao; William 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 394 KB